Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study

• Motoko Tanaka ,

  * E-mail: tanaka@matusita-kai.or.jp

  Affiliation Department of Nephrology, Akebono Clinic, Kumamoto, Japan

  ⨯
• Kazuki Yoshida,

  Affiliations Departments of Epidemiology & Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusettes, United States of America, Institute for Health Outcomes and Process Evaluation Research (iHope International), Kyoto, Japan

  ⨯
• Shingo Fukuma,

  Affiliations Institute for Health Outcomes and Process Evaluation Research (iHope International), Kyoto, Japan, Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan

  ⨯
• Kazuko Ito,

  Affiliation Department of Nephrology, Akebono Clinic, Kumamoto, Japan

  ⨯
• Kazutaka Matsushita,

  Affiliation Department of Nephrology, Akebono Clinic, Kumamoto, Japan

  ⨯
• Masafumi Fukagawa,

  Affiliation Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan

  ⨯
• Shunichi Fukuhara,

  Affiliations Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan, Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan

  ⨯
• Tadao Akizawa

  Affiliation Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan

  ⨯